This study, published in Ophthalmology Science, is a pivotal moment for VR perimetry, addressing the long-standing question regarding the accuracy of VR solutions in patients with advanced glaucoma.
“One of the main concerns surrounding virtual reality perimetry has been its limited ability to accurately assess patients with advanced glaucoma. We demonstrated that VisionOne maintains excellent agreement with the gold standard across the entire disease spectrum,” says Serife Kucur, CTO and co-founder of PeriVision.